Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tauriga Sciences

Tauriga Sciences
2001 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
TAUG STOCK SYMBOL
3 INVESTMENTS
$0.05 SHARE PRICE (As of Friday Closing)
Description

Tauriga Sciences Inc is a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. One such opportunity on which the company has acted involves the company having entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD infused chewing gum product has been branded under Tauri-Gum.

Website
Formerly Known As
Novo Energies Corp, Atlantic Wine Agencies, Immunovative
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Household Products
Environmental Services (B2B)
Conglomerates
Stock Exchange
PINX
Primary Office
  • 39 Old Ridgebury Road
  • Hartford, CT 06180
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Tauriga Sciences’s full profile, request a free trial.

Tauriga Sciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.02 - $0.36 $4.2M $0.05 -$0.04 729K 80.2M

Tauriga Sciences Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 2,745 10,886 2,272 3,359
Revenue 171 57 0 0
EBITDA (1,724) (814) 295 (1,447)
Net Income (2,278) (1,097) (36) (2,176)
Total Assets 659 961 689 4
Total Debt 338 214 255 580
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tauriga Sciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tauriga Sciences‘s full profile, request access.

Request full access to PitchBook

Tauriga Sciences Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 10-Jul-2014 000000000000000000 00.000 Personal Products 000000 0000 00.0
00000 000000 28-Jan-2014 000000000000000000 000 Environmental Services (B2B) 000000 0000 00.0
Immunovative Clinical Research 19-May-2011 Merger/Acquisition Other Pharmaceuticals and Biotechnology 0000000 00000000
To view this company’s complete investment and acquisition history, request access »

Tauriga Sciences Executive Team (10)

Name Title Board
Seat
Contact
Info
Antonio Treminio Chief Executive Officer & Chief Financial Officer
Seth Shaw Chief Executive Officer & Board Member
Bruno Vanderschelden Member of Advisory Board
Lawrence May MD Chief Medical Officer
Stella Sung Ph.D Chairman & Chief Executive Officer

5 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Tauriga Sciences Board Members (5)

Name Representing Role Since Contact
Info
00000 00000000 Self Board Member 000 0000
0000000 00000 Self Board Member 000 0000
0000 0000 Tauriga Sciences Chief Executive Officer & Board Member 000 0000
000000 0000 00.0 Self Chairman & Chief Executive Officer 000 0000
000000 000000 00 Tauriga Sciences Board Member 000 0000